{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:09:47Z","timestamp":1784880587727,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Basel Science Foundation","award":["DMS2297"],"award-info":[{"award-number":["DMS2297"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s40264-018-0711-x","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T01:57:17Z","timestamp":1534384637000},"page":"55-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case\u2013Control Study"],"prefix":"10.1007","volume":"42","author":[{"given":"Noel","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph R.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Spoendlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"7","key":"711_CR1","first-page":"625","volume":"13","author":"M Paulmann","year":"2015","unstructured":"Paulmann M, Mockenhaupt M. Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy. J Dtsch Dermatol Ges. 2015 Jul;13(7):625\u201345.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"6","key":"711_CR2","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","volume":"39","author":"R Gerull","year":"2011","unstructured":"Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med. 2011;39(6):1521\u201332.","journal-title":"Crit Care Med"},{"key":"711_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000335627","volume":"97","author":"T Harr","year":"2012","unstructured":"Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem Immunol Allergy. 2012 Jan;97:149\u201366.","journal-title":"Chem Immunol Allergy"},{"issue":"1","key":"711_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008 Jan;128(1):35\u201344.","journal-title":"J Invest Dermatol."},{"issue":"24","key":"711_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"J Roujeau","year":"1995","unstructured":"Roujeau J, Kelly J, Naldi L, Rzany B, Stern R, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333(24):1600\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"711_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/jcp.0b013e3181604015","volume":"28","author":"GW Jonsson","year":"2008","unstructured":"Jonsson GW, Moosa MY, Jeenah FY. Toxic epidermal necrolysis and fluoxetine: a case report. J Clin Psychopharmacol. 2008;28(1):93\u20135.","journal-title":"J Clin Psychopharmacol"},{"issue":"8866","key":"711_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0140-6736(93)91852-D","volume":"342","author":"P Wolkenstein","year":"1993","unstructured":"Wolkenstein P, Revuz J, Diehl J, Langeron O, Roupie E, Machet L. Toxic epidermal necrolysis after fluvoxamine. Lancet. 1993;342(8866):304\u20135.","journal-title":"Lancet"},{"issue":"3","key":"711_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.genhosppsych.2008.07.006","volume":"31","author":"E Tudela","year":"2009","unstructured":"Tudela E, Villier C, Mallaret M. Toxic epidermal necrolysis associated with paroxetine. Gen Hosp Psychiatry. 2009 Jan;31(3):297\u20138.","journal-title":"Gen Hosp Psychiatry"},{"issue":"10","key":"711_CR9","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1111\/j.1398-9995.2009.02036.x","volume":"64","author":"A Belkahia","year":"2009","unstructured":"Belkahia A, Hillaire-Buys D, Dereure O, Guillot B, Raison-Peyron N. Stevens-Johnson syndrome due to mirtazapine: first case. Allergy. 2009 Oct;64(10):1554.","journal-title":"Allergy"},{"issue":"1","key":"711_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/cap.2010.0071","volume":"21","author":"J Strawn","year":"2011","unstructured":"Strawn J, Whitsel R, Nandagopal J, Delbello M. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine. J Child Adolesc Psychopharmacol. 2011;21(1):91\u20132.","journal-title":"J Child Adolesc Psychopharmacol."},{"issue":"10","key":"711_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.4088\/JCP.v65n1020d","volume":"65","author":"N Weiss","year":"2004","unstructured":"Weiss N, Jones L, Chamberlain J. A possible case of venlafaxine-induced Stevens-Johnson syndrome. J Clin Psychiatry. 2004;65(10):1431\u20133.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"711_CR12","first-page":"699","volume":"16","author":"M Casacci","year":"2006","unstructured":"Casacci M, Lebas D, Decamps F, Fourrier F, Delaporte E. Toxic epidermal necrolysis due to omeprazole. Eur J Dermatol. 2006;16(6):699\u2013700.","journal-title":"Eur J Dermatol."},{"issue":"6","key":"711_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1365-2230.2004.01616.x","volume":"29","author":"N Heaton","year":"2004","unstructured":"Heaton N, Edmonds E, Francis N, Bunker C, Bowling J, Morar N. Fatal toxic epidermal necrolysis due to lansoprazole. Clin Exp Dermatol. 2004;29(6):612\u20133.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"711_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/JCP.0000000000000641","volume":"37","author":"D Moubayed","year":"2017","unstructured":"Moubayed D, Gifuni A, Tourian L. Methotrimeprazine-associated Stevens-Johnson syndrome in 2 Ashkenazi Jewish patients. J Clin Psychopharmacol. 2017;37(1):112\u20133.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"711_CR15","first-page":"01","volume":"10","author":"P Kumar","year":"2016","unstructured":"Kumar P, Chauhan A, Haraniya R, Ghosh A, Tandon V. Metolazone associated Stevens Johnson syndrome-toxic epidermal necrolysis overlap. J Clin Diagn Res. 2016;10(3):01\u20132.","journal-title":"J Clin Diagn Res."},{"issue":"2","key":"711_CR16","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2125.2008.03340.x","volume":"67","author":"T Jao","year":"2009","unstructured":"Jao T, Tsai T-H, Jeng J-S. Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome. Br J Clin Pharmacol. 2009 Feb;67(2):264\u20135.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"711_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/JCP.0000000000000482","volume":"36","author":"A Struye","year":"2016","unstructured":"Struye A, Depuydt C, Abdel-Sater E, Dubois V. Toxic epidermal necrolysis related to paliperidone palmitate: first case report. J Clin Psychopharmacol. 2016;36(3):279\u201382.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"711_CR18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00198-014-2688-3","volume":"25","author":"C-Y Yang","year":"2014","unstructured":"Yang C-Y, Chen C-H, Wang H-Y, Hsiao H-L, Hsiao Y-H, Chung W-H. Strontium ranelate related Stevens-Johnson syndrome: a case report. Osteoporos Int. 2014 Jun;25(6):1813\u20136.","journal-title":"Osteoporos Int"},{"issue":"8","key":"711_CR19","first-page":"1010","volume":"9","author":"J Surovik","year":"2010","unstructured":"Surovik J, Riddel C, Chon S. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. J Drugs Dermatol. 2010;9(8):1010\u20132.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"711_CR20","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1345\/aph.1R637","volume":"47","author":"M Pretel-Irazabal","year":"2013","unstructured":"Pretel-Irazabal M, Marquez-Martin L, Aguado-Gil L, Idoate-Gastearena M. Tranexamic acid-induced toxic epidermal necrolysis. Ann Pharmacother. 2013;47(3):e16.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"711_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/ibd.20125","volume":"13","author":"K Fukunaga","year":"2007","unstructured":"Fukunaga K, Ohda Y, Inoue T, Kono T, Miwa H, Matsumoto T. Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis. Inflamm Bowel Dis. 2007 Aug;13(8):1055\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"711_CR22","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2165\/00002018-200528100-00008","volume":"28","author":"L Grenade La","year":"2005","unstructured":"La Grenade L, Lee L, Weaver J, Bonnel R, Karowski C, Governale L, et al. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. Drug Saf. 2005;28(10):917\u201324.","journal-title":"Drug Saf"},{"issue":"4","key":"711_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-4632.2006.02654.x","volume":"45","author":"F Delesalle","year":"2006","unstructured":"Delesalle F, Carpentier O, Guatier S, Delaporte E. Toxic epidermal necrolysis caused by tetrazepam. Int J Dermatol. 2006;45(4):480.","journal-title":"Int J Dermatol"},{"issue":"8","key":"711_CR24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40264-013-0070-6","volume":"36","author":"C Haddad","year":"2013","unstructured":"Haddad C, Sidoroff A, Kardaun SH, Mockenhaupt M, Creamer D, Dunant A, et al. Stevens-Johnson syndrome\/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk? Drug Saf. 2013;36(8):681\u20136.","journal-title":"Drug Saf"},{"issue":"12","key":"711_CR25","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1111\/epi.13925","volume":"58","author":"N Frey","year":"2017","unstructured":"Frey N, Bodmer M, Bircher A, R\u00fcegg S, Jick SS, Meier CR, et al. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Epilepsia. 2017;58(12):2178\u201385.","journal-title":"Epilepsia."},{"issue":"5","key":"711_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jid.2017.12.015","volume":"138","author":"N Frey","year":"2018","unstructured":"Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J. Antibiotic drug use and the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based case-control study. J Invest Dermatol. 2018;138(5):1207\u20139.","journal-title":"J Invest Dermatol."},{"issue":"3","key":"711_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"711_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010 Jan;69(1):4\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"711_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/pds.4124","volume":"26","author":"N Frey","year":"2017","unstructured":"Frey N, Bircher A, Bodmer M, Jick SS, Meier CR, Spoendlin J. Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 2017;26(4):429\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"711_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.leukres.2012.03.006","volume":"36","author":"M Lambertini","year":"2012","unstructured":"Lambertini M, Del Mastro L, Gardin G, Levaggi A, Bighin C, Giraudi S, et al. Stevens-Johnson syndrome after treatment with bendamustine. Leuk Res. 2012;36(7):153\u20134.","journal-title":"Leuk Res"},{"key":"711_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2016.02.015","volume":"95","author":"J Doesch","year":"2016","unstructured":"Doesch J, Debus D, Meyer C, Papadopoulos T, Schultz ES, Ficker JH, et al. Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient. Lung Cancer. 2016;95:35\u20138.","journal-title":"Lung Cancer."},{"issue":"4","key":"711_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1159\/000351918","volume":"91","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Fujita T, Amoh Y, Mii S, Matsumoto K, Iwamura M. Stevens-Johnson syndrome induced by sorafenib for metastatic renal cell carcinoma. Urol Int. 2013;91(4):482\u20133.","journal-title":"Urol Int"},{"issue":"1","key":"711_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case\u2013control analysis. Clin Pharmacol Ther. 2010;88(1):60\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"711_CR34","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","volume":"64","author":"M Mockenhaupt","year":"2005","unstructured":"Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology. 2005 Apr 12;64(7):1134\u20138.","journal-title":"Neurology."},{"issue":"11","key":"711_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.amjmed.2016.03.022","volume":"129","author":"MA Miliszewski","year":"2016","unstructured":"Miliszewski MA, Kirchhof MG, Sikora S, Papp A, Dutz JP. Stevens-Johnson syndrome and toxic epidermal necrolysis: an analysis of triggers and implications for improving prevention. Am J Med. 2016;129(11):1221\u20135.","journal-title":"Am J Med"},{"issue":"6","key":"711_CR36","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jid.2017.01.031","volume":"137","author":"N Frey","year":"2017","unstructured":"Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, et al. The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UK. J Invest Dermatol. 2017;137(6):1240\u20137.","journal-title":"J Invest Dermatol."},{"issue":"8","key":"711_CR37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/PEC.0000000000000195","volume":"30","author":"RA Burns","year":"2014","unstructured":"Burns RA, Topoz I, Reynolds SL. Tumor lysis syndrome: risk factors, diagnosis, and management. Pediatr Emerg Care. 2014;30(8):571\u20136.","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"711_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jamda.2012.10.018","volume":"14","author":"Barreto P Souto de","year":"2013","unstructured":"de Souto Barreto P, Lapeyre-Mestre M, Mathieu C, Piau C, Bouget C, Cayla F, et al. Prevalence and associations of the use of proton-pump inhibitors in nursing homes: a cross-sectional study. J Am Med Dir Assoc. 2013;14(4):265\u20139.","journal-title":"J Am Med Dir Assoc."},{"issue":"6","key":"711_CR39","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, et al. UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016;174(6):1194\u2013227.","journal-title":"Br J Dermatol"},{"issue":"3","key":"711_CR40","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1111\/pde.12527","volume":"32","author":"CD Dang","year":"2015","unstructured":"Dang CD, Beets-Shay L, Kahn EC. Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl. Pediatr Dermatol. 2015;32(3):e102\u20133.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"711_CR41","first-page":"55","volume":"26","author":"I S\u00e1nchez","year":"1998","unstructured":"S\u00e1nchez I, Garc\u00eda-Abujeta JL, Fern\u00e1ndez L, Rodr\u00edguez F, Qui\u00f1ones D, Duque S, et al. Stevens-Johnson syndrome from tetrazepam. Allergol Immunopathol (Madr). 1998;26(2):55\u20137.","journal-title":"Allergol Immunopathol (Madr)."},{"key":"711_CR42","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","volume":"136","author":"DY Hsu","year":"2016","unstructured":"Hsu DY, Brieva J, Silverberg NB, Silverberg JI. Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults. J Invest Dermatol. 2016;136:1387\u201397.","journal-title":"J Invest Dermatol."},{"issue":"8","key":"711_CR43","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schroder W, Roujeau J-C. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol. 2002;138(8):1019\u201324.","journal-title":"Arch Dermatol"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-018-0711-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0711-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T16:11:52Z","timestamp":1568736712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-018-0711-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["711"],"URL":"https:\/\/doi.org\/10.1007\/s40264-018-0711-x","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"16 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by the University of Basel Science Foundation (Grant No. DMS2297).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Noel Frey, Michael Bodmer, Andreas Bircher, Susan S. Jick, Christoph R. Meier, and Julia Spoendlin have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}